Bayer Aktiengesellschaft (ETR:BAYN)
26.69
-0.25 (-0.91%)
Jun 20, 2025, 5:41 PM CET
Bayer Aktiengesellschaft Employees
Bayer Aktiengesellschaft had 91,864 employees as of December 31, 2024. The number of employees decreased by 5,067 or -5.23% compared to the previous year.
Employees
91,864
Change (1Y)
-5,067
Growth (1Y)
-5.23%
Revenue / Employee
€512,505
Profits / Employee
€35,792
Market Cap
26.22B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 91,864 | -5,067 | -5.23% |
Dec 31, 2023 | 96,931 | -991 | -1.01% |
Dec 31, 2022 | 97,922 | 1,972 | 2.06% |
Dec 31, 2021 | 95,950 | -5 | -0.01% |
Dec 31, 2020 | 95,955 | -2,782 | -2.82% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Merck KGaA | 59,020 |
Fresenius SE & Co. KGaA | 176,486 |
Fresenius Medical Care AG | 111,513 |
Sartorius Aktiengesellschaft | 13,528 |
Carl Zeiss Meditec AG | 5,730 |
Fielmann Group AG | 24,363 |
SCHOTT Pharma AG & Co. KGaA | 4,690 |
Bayer Aktiengesellschaft News
- 4 days ago - Bayer’s stock is charting a 40% rebound after years of losses - Fortune
- 5 days ago - Bayer Files for Approval of gadoquatrane in the U.S. - Business Wire
- 5 days ago - Captain T Cell Joins Bayer Co.Lab Berlin to Accelerate Autologous and Allogeneic TCR-T Cell Therapy Programs for Cancer Patients - GlobeNewsWire
- 6 days ago - Bayer Innovation Procurement Expands Use of Scientist.com's AI-Powered Platform for Global R&D Procurement Orchestration - Business Wire
- 11 days ago - Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies - Business Wire
- 16 days ago - Bayer raised to Buy at Goldman after hitting bottom of negative earnings revision cycle - Seeking Alpha
- 17 days ago - Bayer Crop Science delegation visits ISARC - The Times of India
- 18 days ago - Bayer subsidiary gains worldwide rights to develop cancer asset VVD-214 - Seeking Alpha